Ondansetron Injection, Solution
Product Images NDC 67184-0507

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 67184-0507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Formula Of Ondansetron (Ondansetron 01)

Chemical structure of ondansetron shown with its molecular formula including a benzodiazepine ring system, a methyl group, and a chlorinated hydrate component (HCl·2H2O).*

FDA Label Image

Ondansetron Injection Usp Label Image (2mL Single-use Vials)

ONDANSETRON Injection USP 4 mg per 2 mL (2 mg/mL) solution in a 2 mL single-dose vial. The label indicates it is for intramuscular or intravenous use only, prescription only, manufactured by Qilu Pharmaceutical Co., Ltd. in Haikou, China. The label also includes the NDC 67184-0507-1 and a barcode.*

FDA Label Image

Ondansetron Injection Usp Label Image (5 x 2mL Single-use Vials)

ONDANSETRON Injection USP 4 mg/2 mL (2 mg/mL) solution, labeled for intramuscular or intravenous use, packaged as 5 single-dose 2 mL vials. The label indicates it is Rx only, sterile, and manufactured by Qilu Pharmaceutical Co., Ltd. The packaging includes standard storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.